More on GNPX

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (6.7 Score)
- Holders

Upcoming Events

- Earnings (11/17/25 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Genprex (NQ:GNPX)
Delayed: 1.95 -0.05 (2.5%)
Prev. Close $2.00  
Open$1.99 
52 Wk High$ 
52 Wk Low$ 
Day High$2.03 
Day Low$1.94 
P/E N/A  
EPS$ 
Volume316,015 


Feb 27, 2026 06:34 PM Form 4 Genprex, Inc. For: Feb 27 Filed by: Berger Mark Stanley
Feb 27, 2026 06:33 PM Form 4 Genprex, Inc. For: Feb 27 Filed by: Confer Ryan M.
Feb 23, 2026 08:08 AM Form 8-K Genprex, Inc. For: Feb 23
Feb 23, 2026 08:02 AM Genprex receives Japanese and EU patents for cancer gene therapy combinations
Feb 23, 2026 08:00 AM Genprex Strengthens Intellectual Property Portfolio with Japanese and EU Patents for Reqorsa® Gene Therapy in Combination with Immunotherapies to Treat Cancer
Feb 11, 2026 10:06 AM Form SCHEDULE 13G Genprex, Inc. Filed by: Ayrton Capital LLC
Feb 10, 2026 08:05 AM Form 8-K Genprex, Inc. For: Feb 10
Feb 10, 2026 08:00 AM Genprex receives Australian patent approval for Reqorsa cancer therapy
Feb 10, 2026 08:00 AM Genprex Announces IP Australia's Intent to Grant Patent for Reqorsa® Gene Therapy in Combination with PD-L1 Antibodies to Treat Cancers
Jan 9, 2026 04:59 PM Form 8-K Genprex, Inc. For: Jan 07
View All Articles

Entities mentioned with GNPX

View All Entities